Related Experiment Video
Updated: Feb 15, 2026

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024
High nuclear MSK1 is associated with longer survival in breast cancer patients
Xuan Pu1, Sarah J Storr1, Narmeen S Ahmad1
1University of Nottingham, Division of Cancer and Stem Cells, Department of Clinical Oncology, School of Medicine, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, UK.
Purpose:
Mitogen- and stress-activated kinases (MSKs) are important substrates of the mitogen-activated protein kinase (MAPK)-activated protein kinase family. MSK1 and MSK2 are both nuclear serine/threonine protein kinases, with MSK1 being suggested to potentially play a role in breast cancer cell proliferation, cell cycle progression, cell migration, invasion and tumour growth. The aim of the current study was to assess MSK1 protein expression in breast cancer tumour specimens, evaluating its prognostic significance.
Methods:
A large cohort of 1902 early stage invasive breast cancer patients was used to explore the expression of MSK1. Protein expression was examined using standard immunohistochemistry on tissue microarrays.
Results:
Low MSK1 protein expression was associated with younger age (P = 0.004), higher tumour grade (P < 0.001), higher Nottingham Prognostic Index scores (P = 0.007), negative ER (P < 0.001) and PR (P < 0.001) status, and with triple-negative (P < 0.001) and basal-like (P < 0.001) phenotypes. Low MSK1 protein expression was significantly associated with shorter time to distant metastasis (P < 0.001), and recurrence (P = 0.013) and early death due to breast cancer (P = 0.01). This association between high MSK1 expression and improved breast cancer-specific survival was observed in the whole cohort (P = 0.009) and in the HER2-negative and non-basal like tumours (P = 0.006 and P = 0.024, respectively). Multivariate analysis including other prognostic variables indicated that MSK1 is not an independent marker of outcome.
Conclusions:
High MSK1 is associated with improved breast cancer-specific survival in early stage invasive breast cancer patients, and has additional prognostic value in HER2-negative and non-basal like disease. Although not an independent marker of outcome, we believe such findings and significant associations with well-established negative prognostic factors (age, grade, Nottingham Prognostic Index, hormone receptor status, time to distant metastasis, recurrence and triple-negative/basal-like status) warrant further examination and validation in independent patient cohorts.
Insights
High MSK1 protein expression is linked to better survival in early breast cancer patients. While not an independent marker, its association with known negative prognostic factors warrants further study.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Mitogen- and stress-activated kinases (MSKs), including MSK1 and MSK2, are nuclear serine/threonine protein kinases.
- MSK1 has been implicated in breast cancer cell proliferation, cell cycle progression, migration, invasion, and tumor growth.
Purpose of the Study:
- To assess MSK1 protein expression in breast cancer tumor specimens.
- To evaluate the prognostic significance of MSK1 expression in early-stage invasive breast cancer.
Main Methods:
- Utilized a cohort of 1902 early-stage invasive breast cancer patients.
- Examined MSK1 protein expression using standard immunohistochemistry on tissue microarrays.
Main Results:
- Low MSK1 expression correlated with younger age, higher tumor grade, higher Nottingham Prognostic Index, negative ER/PR status, and triple-negative/basal-like phenotypes.
- Low MSK1 expression was significantly associated with shorter time to distant metastasis, recurrence, and early death.
- High MSK1 expression was linked to improved breast cancer-specific survival, particularly in HER2-negative and non-basal like tumors.
Conclusions:
- High MSK1 expression is associated with improved breast cancer-specific survival in early-stage invasive breast cancer.
- MSK1 has additional prognostic value in HER2-negative and non-basal like disease.
- Despite not being an independent marker, MSK1's associations with established negative prognostic factors suggest further investigation and validation in independent cohorts are warranted.
Related Concept Videos
Cancer Survival Analysis
Nuclear Stability
To hold positively charged protons together...
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Non-nuclear Inheritance
Nuclear Export of mRNA
Nuclear Transmutation

